Save 20% on your next Cambridge Bioethics and Law online purchase
Page URL: https://www.bionews.org.uk/page_90500

Nobel Prize awarded for revolutionary gene-targeting method in mice

15 October 2007
Appeared in BioNews 429

Last week the Nobel Prize for Medicine was jointly awarded to three scientists for their pioneering work on embryonic stem cells (ES cells) in mice. The trio, comprising US scientists Mario R. Capecchi and Oliver Smithies, and UK scientist Martin J. Evans, developed a technique known as 'gene targeting', which has since helped scientists worldwide to establish the roles that a whole host of individual genes play in health and disease.

The Nobel committee said: 'their discoveries led to the creation of an immensely powerful technology...now being applied to virtually all areas of biomedicine - from basic research to the development of new therapies.'

Each scientist made their own unique contribution to this revolutionary technology. Sir Evans, Professor of Mammalian Genetics at Cardiff University, discovered that embryonic stem cells  from mice had the power to develop into any tissues of the body, and that harmless 'retroviruses' could be used to insert new gene sequences into these cells. By injecting these genetically modified ES cells into a developing mouse embryo inside a female mouse, and then breeding the resulting offspring with a normal mouse, he found that a new genetically modified mouse could be created.

The ability to induce targeted gene changes within the mouse genome- known as a gene 'knockout' - arose from independent work by Capecchi and Smithies. By using this technology to introduce specific genetic modifications into mouse ES cells they were able to create mouse models of human genetic disorders, helping scientists worldwide to develop a better understanding of human health and disease.

Goran Hansson, a member of the Nobel committee, told the Independent newspaper that targeting genes had transformed the understanding of human physiology and medicine. 'It is difficult to imagine contemporary medical research without the use of gene-targeted models', he added. 'The ability to generate predictable designer mutations in mouse genes has led to penetrating new insights into development, immunology, neurobiology, physiology and metabolism'.

The Nobel committee believe that the major benefits to human health gained from knockout mouse technology will not end here. 'Gene targeting has already produced more than five hundred different mouse models of human disorders, including cardiovascular and neuro-degenerative diseases, diabetes and cancer', they said. 'Its impact on the understanding of gene function and its benefits to mankind will continue to increase over many years to come'.

SOURCES & REFERENCES
Gene targeting method wins 2007 Nobel Prize in Medicine
phg foundation |  8 October 2007
Key gene work scoops Nobel prize
BBC News Online |  8 October 2007
The breakthrough of 'gene targeting'
The Independent |  9 October 2007
The Nobel Prize in Physiology or Medicine 2007: Press Release
Nobelprize.org |  8 October 2007
RELATED ARTICLES FROM THE BIONEWS ARCHIVE
11 November 2013 - by Dr James Heather 
The chance to watch a lecture from a Nobel laureate is always exciting. Throw in a couple of scientific societies that clock up over 400 years of history between them, and you can practically feel the prestige dripping from the ceiling...
8 October 2012 - by Antony Starza-Allen 
Professor Sir John Gurdon of the University of Cambridge has been jointly awarded the Nobel Prize for his work on stem cells. He shares the prize for medicine or physiology with Professor Shinya Yamanaka from Japan...
10 October 2011 - by Dr Rebecca Robey 
The winners of the Nobel Prize in Physiology or Medicine 2011 were announced on 3 October with an unusual twist – for the first time the accolade has been bestowed on someone posthumously. This is normally against the Nobel Assembly's rules, but Professor Ralph Steinman's untimely death on 30 September occurred after messages had been sent to him informing him of his success...
HAVE YOUR SAY
Log in to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions


Syndicate this story - click here to enquire about using this story.